HK Stock MarketDetailed Quotes

02181 MABPHARM-B

Watchlist
  • 0.325
  • -0.015-4.41%
Not Open Nov 28 16:08 CST
1.34BMarket Cap-5909P/E (TTM)

MABPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
146.44%108.48M
55.87%87.16M
52.60%44.02M
-32.53%55.92M
-64.49%28.85M
--82.88M
--81.25M
----
----
----
Operating income
146.44%108.48M
55.87%87.16M
52.60%44.02M
-32.53%55.92M
-64.49%28.85M
82.88M
81.25M
Cost of sales
-127.93%-14.13M
22.45%-11.92M
43.93%-6.2M
8.36%-15.38M
34.08%-11.05M
---16.78M
---16.77M
----
----
----
Operating expenses
-127.93%-14.13M
22.45%-11.92M
43.93%-6.2M
8.36%-15.38M
34.08%-11.05M
-16.78M
-16.77M
Gross profit
149.47%94.36M
85.58%75.24M
112.57%37.82M
-38.67%40.54M
-72.40%17.79M
66.11M
64.48M
Selling expenses
-157.35%-69.6M
-73.41%-48.93M
-77.18%-27.05M
-199.41%-28.21M
---15.26M
---9.42M
----
----
----
----
Administrative expenses
-28.62%-60.65M
-15.57%-104.66M
1.42%-47.15M
0.08%-90.56M
-9.32%-47.83M
-37.75%-90.63M
-42.33%-43.76M
-4.52%-65.8M
-10.25%-30.74M
-49.43%-62.95M
Research and development expenses
5.43%-56.29M
16.70%-123.21M
23.67%-59.53M
43.88%-147.91M
52.29%-77.99M
-118.88%-263.57M
-168.72%-163.46M
10.26%-120.42M
-3.62%-60.83M
-50.80%-134.19M
Impairment and provision
-18.31%-756K
-261.86%-427K
---639K
---118K
----
----
----
----
----
----
-Other impairment is provision
-18.31%-756K
-261.86%-427K
---639K
---118K
----
----
----
----
----
----
Special items of operating profit
-23.90%793K
-90.25%2.21M
-89.13%1.04M
176.49%22.62M
925.84%9.59M
48.13%8.18M
-102.90%-1.16M
-81.49%5.52M
1,564.10%40.01M
226.95%29.83M
Operating profit
3.51%-92.15M
1.89%-199.78M
16.01%-95.5M
29.62%-203.63M
20.98%-113.71M
-60.13%-289.34M
-179.06%-143.89M
-8.00%-180.69M
38.75%-51.56M
-37.15%-167.31M
Financing cost
-20.45%-5.42M
-33.25%-9.58M
-44.91%-4.5M
-199.13%-7.19M
-144.99%-3.1M
39.04%-2.4M
51.71%-1.27M
48.77%-3.94M
33.95%-2.62M
-71.73%-7.7M
Special items of earning before tax
----
----
----
----
----
----
----
----
----
-5.36%-27.53M
Earning before tax
2.43%-97.57M
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-32.72%-202.53M
After-tax profit from continuing operations
2.43%-97.57M
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-35.24%-202.53M
Earning after tax
2.43%-97.57M
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-35.24%-202.53M
Profit attributable to shareholders
2.43%-97.57M
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-62.17%-202.53M
Basic earnings per share
0.00%-0.02
0.00%-0.05
33.33%-0.02
28.57%-0.05
25.00%-0.03
-75.00%-0.07
-300.00%-0.04
20.00%-0.04
66.67%-0.01
16.67%-0.05
Diluted earnings per share
0.00%-0.02
0.00%-0.05
33.33%-0.02
28.57%-0.05
25.00%-0.03
-75.00%-0.07
-300.00%-0.04
20.00%-0.04
66.67%-0.01
16.67%-0.05
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 146.44%108.48M55.87%87.16M52.60%44.02M-32.53%55.92M-64.49%28.85M--82.88M--81.25M------------
Operating income 146.44%108.48M55.87%87.16M52.60%44.02M-32.53%55.92M-64.49%28.85M82.88M81.25M
Cost of sales -127.93%-14.13M22.45%-11.92M43.93%-6.2M8.36%-15.38M34.08%-11.05M---16.78M---16.77M------------
Operating expenses -127.93%-14.13M22.45%-11.92M43.93%-6.2M8.36%-15.38M34.08%-11.05M-16.78M-16.77M
Gross profit 149.47%94.36M85.58%75.24M112.57%37.82M-38.67%40.54M-72.40%17.79M66.11M64.48M
Selling expenses -157.35%-69.6M-73.41%-48.93M-77.18%-27.05M-199.41%-28.21M---15.26M---9.42M----------------
Administrative expenses -28.62%-60.65M-15.57%-104.66M1.42%-47.15M0.08%-90.56M-9.32%-47.83M-37.75%-90.63M-42.33%-43.76M-4.52%-65.8M-10.25%-30.74M-49.43%-62.95M
Research and development expenses 5.43%-56.29M16.70%-123.21M23.67%-59.53M43.88%-147.91M52.29%-77.99M-118.88%-263.57M-168.72%-163.46M10.26%-120.42M-3.62%-60.83M-50.80%-134.19M
Impairment and provision -18.31%-756K-261.86%-427K---639K---118K------------------------
-Other impairment is provision -18.31%-756K-261.86%-427K---639K---118K------------------------
Special items of operating profit -23.90%793K-90.25%2.21M-89.13%1.04M176.49%22.62M925.84%9.59M48.13%8.18M-102.90%-1.16M-81.49%5.52M1,564.10%40.01M226.95%29.83M
Operating profit 3.51%-92.15M1.89%-199.78M16.01%-95.5M29.62%-203.63M20.98%-113.71M-60.13%-289.34M-179.06%-143.89M-8.00%-180.69M38.75%-51.56M-37.15%-167.31M
Financing cost -20.45%-5.42M-33.25%-9.58M-44.91%-4.5M-199.13%-7.19M-144.99%-3.1M39.04%-2.4M51.71%-1.27M48.77%-3.94M33.95%-2.62M-71.73%-7.7M
Special items of earning before tax -------------------------------------5.36%-27.53M
Earning before tax 2.43%-97.57M0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-32.72%-202.53M
After-tax profit from continuing operations 2.43%-97.57M0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-35.24%-202.53M
Earning after tax 2.43%-97.57M0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-35.24%-202.53M
Profit attributable to shareholders 2.43%-97.57M0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-62.17%-202.53M
Basic earnings per share 0.00%-0.020.00%-0.0533.33%-0.0228.57%-0.0525.00%-0.03-75.00%-0.07-300.00%-0.0420.00%-0.0466.67%-0.0116.67%-0.05
Diluted earnings per share 0.00%-0.020.00%-0.0533.33%-0.0228.57%-0.0525.00%-0.03-75.00%-0.07-300.00%-0.0420.00%-0.0466.67%-0.0116.67%-0.05
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data